de novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita

1 Walne AJ, Marrone A, Dokal I: Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol 2005; 82:184–189. WalneAJ MarroneA DokalI Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol 2005 82 184 189 10.1532/IJH97.0506716207588 Search in Google Scholar

2 Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000; 110: 768–779. DokalI Dyskeratosis congenita in all its forms Br J Haematol 2000 110 768 779 10.1046/j.1365-2141.2000.02109.x11054058 Search in Google Scholar

3 Bessler M, Wilson DB, Mason PJ. Dyskeratosis congenita. FEBS Lett. 2010; 584: 3831–3838. BesslerM WilsonDB MasonPJ Dyskeratosis congenita FEBS Lett 2010 584 3831 3838 10.1016/j.febslet.2010.05.019323845120493861 Search in Google Scholar

4 Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013; 6: 327–37. BallewBJ SavageSA Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders Expert Rev Hematol 2013 6 327 37 10.1586/ehm.13.2323782086 Search in Google Scholar

5 Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009; 113(26): 6549–57. AlterBP GiriN SavageSA RosenbergPS Cancer in dyskeratosis congenita Blood 2009 113 26 6549 57 10.1182/blood-2008-12-192880271091519282459 Search in Google Scholar

6 Heiss NS, Knight SW, Vulliamy T, SM Klauck, S Wiemann, P J Mason et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998; 19: 32–38. HeissNS KnightSW VulliamyT KlauckSM WiemannS MasonP J X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions Nat Genet 1998 19 32 38 10.1038/ng0598-329590285 Search in Google Scholar

7 Walne AJ, Dokal I: Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009; 145: 164–172. WalneAJ DokalI Advances in the understanding of dyskeratosis congenita Br J Haematol 2009 145 164 172 10.1111/j.1365-2141.2009.07598.x288222919208095 Search in Google Scholar

8 Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP: TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008; 82: 501–509. SavageSA GiriN BaerlocherGM OrrN LansdorpPM AlterBP TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita Am J Hum Genet 2008 82 501 509 10.1016/j.ajhg.2007.10.004242722218252230 Search in Google Scholar

9 Calado RT (ed): Progress in Molecular Biology and Translational Science, ed 1. Waltham, Academic Press, 2014. CaladoRT (ed): Progress in Molecular Biology and Translational Science ed 1. Waltham Academic Press 2014 Search in Google Scholar

10 Du HY, Mason PJ, Bessler M, and Wilson DB. Pediatr. Blood Cancer. 2009; 52: 687. DuHY MasonPJ BesslerM WilsonDB Pediatr Blood Cancer 2009 52 687 10.1002/pbc.21903286079219090550 Search in Google Scholar

11 Tsangaris E, Adams SL, Yoon G, Chitayat D, Lansdorp P, Dokal I, and Dror Y. Hum. Genet. 2008; 124: 507–513. TsangarisE AdamsSL YoonG ChitayatD LansdorpP DokalI DrorY Hum. Genet. 2008 124 507 513 10.1007/s00439-008-0576-718979121 Search in Google Scholar

12 Walne AJ, Vulliamy T, Beswick R, Michael K, Dokal I. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood. 2008; 112(9): 3594–3600. WalneAJ VulliamyT BeswickR MichaelK DokalI TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes Blood 2008 112 9 3594 3600 10.1182/blood-2008-05-153445257278818669893 Search in Google Scholar

13 Sarper N, Zengin E, Kilic SC. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex. Pediatr Blood Cancer. 2010; 55(6):1185–1186. SarperN ZenginE KilicSC A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex Pediatr Blood Cancer 2010 55 6 1185 1186 10.1002/pbc.2262420979174 Search in Google Scholar

14 Fukuhara A, Tanino Y, Ishii T, Inokoshi Y, Saito K, Fukuhara N et al. Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation. Eur Respir J. 2013; 42: 1757–1759. FukuharaA TaninoY IshiiT InokoshiY SaitoK FukuharaN Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation Eur Respir J 2013 42 1757 1759 10.1183/09031936.0014911324072216 Search in Google Scholar

15 Savage SA. Dyskeratosis Congenita. 2009 Nov 12 [updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK22301/ Citation on PubMed SavageSA Dyskeratosis Congenita 2009 Nov 12 [updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK22301/ Citation on PubMed Search in Google Scholar

16 Karremann M, Neumaier-Probst E, Schlichtenbrede F, Beier F, Brümmendorf TH, et al. Revesz syndrome revisited. Orphanet J Rare Dis. 2020; 15: 299. KarremannM Neumaier-ProbstE SchlichtenbredeF BeierF BrümmendorfTH Revesz syndrome revisited Orphanet J Rare Dis 2020 15 299 10.1186/s13023-020-01553-y758328733097095 Search in Google Scholar

17 Hongchun D, Yubiao G, Di M, Kejing T, Decheng C, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018; 97(19): e0724. HongchunD YubiaoG DiM KejingT DechengC A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita Medicine (Baltimore) 2018 97 19 e0724 10.1097/MD.0000000000010724595942329742735 Search in Google Scholar

18 Vulliamy T, Beswick R, Kirwan MJ, Hossain U, Walne AJ, and Dokal I. Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TINF2. Clin Genet. 2012; 81(1): 76–81. VulliamyT BeswickR KirwanMJ HossainU WalneAJ DokalI Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TINF2 Clin Genet 2012 81 1 76 81 10.1111/j.1399-0004.2010.01605.x365417121199492 Search in Google Scholar

19 Sasa GS, Ribes-Zamora A. Nelson ND, Bertuch AA. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin Genet. 2012; 81(5): 470–8. SasaGS Ribes-ZamoraA NelsonND BertuchAA Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood Clin Genet 2012 81 5 470 8 10.1111/j.1399-0004.2011.01658.x384487021477109 Search in Google Scholar

20 Gutierrez-Rodrigues F, Donaires FS, Pinto A, Vicente A, Dillon LW et al. Pathogenic TERT promoter variants in telomere diseases. Genet Med. 2019; 21(7): 1594–1602. Gutierrez-RodriguesF DonairesFS PintoA VicenteA DillonLW Pathogenic TERT promoter variants in telomere diseases Genet Med 2019 21 7 1594 1602 10.1038/s41436-018-0385-x655570030523342 Search in Google Scholar

21 Yang D, He Q, Kim H, Ma W, Songyang Z. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J Biol Chem. 2011; 286 (26): 23022–30. YangD HeQ KimH MaW SongyangZ TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase J Biol Chem 2011 286 26 23022 30 10.1074/jbc.M111.225870312307021536674 Search in Google Scholar

22 Li F, Li W, Qiao X, Xie X. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review. Int J Hematol. 2019; 109(3): 328–335. LiF LiW QiaoX XieX Clinical features of dyskeratosis congenita in mainland China: case reports and literature review Int J Hematol 2019 109 3 328 335 10.1007/s12185-018-02582-x30604317 Search in Google Scholar

23 Pereboeva L, Hubbard M, Goldman FD, Westin ER. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells. PLoS One. 2016; 11(2): e0148793. PereboevaL HubbardM GoldmanFD WestinER Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells PLoS One 2016 11 2 e0148793 10.1371/journal.pone.0148793474751026859482 Search in Google Scholar

24 Nelson ND, Dodson LM, Escudero L, Sukumar AT, Williams CL, Mihalek I, et al. The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation and Dyskeratosis Congenita Cluster-Dependent Fashion. Mol Cell Biol. 2018; 38(12): e00025–18. NelsonND DodsonLM EscuderoL SukumarAT WilliamsCL MihalekI The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation and Dyskeratosis Congenita Cluster-Dependent Fashion Mol Cell Biol 2018 38 12 e00025 18 10.1128/MCB.00025-18597443129581185 Search in Google Scholar

25 Norberg A, Rosén A, Raaschou-Jensen K, Kjeldsen L, Moilanen JS, Paulsson-Karlsson Y, et al. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. Eur J Hum Genet. 2018; 26(6): 858–867. NorbergA RosénA Raaschou-JensenK KjeldsenL MoilanenJS Paulsson-KarlssonY Novel variants in Nordic patients referred for genetic testing of telomere-related disorders Eur J Hum Genet 2018 26 6 858 867 10.1038/s41431-018-0112-8597439329483670 Search in Google Scholar

26 Moussa K, Huang JN, Moore AT. Revesz syndrome masquerading as traumatic retinal detachment. J AAPOS. 2017; 21(5): 422–425. MoussaK HuangJN MooreAT Revesz syndrome masquerading as traumatic retinal detachment J AAPOS 2017 21 5 422 425 10.1016/j.jaapos.2017.04.01628866069 Search in Google Scholar

27 Monoi A, Sugawa M, Kato M, Seki M, Yoshida K, Shiraishi Y, et al. Atypical dyskeratosis congenita diagnosed using whole-exome sequencing. Pediatr Int. 2017; 59(8): 933–935. MonoiA SugawaM KatoM SekiM YoshidaK ShiraishiY Atypical dyskeratosis congenita diagnosed using whole-exome sequencing Pediatr Int 2017 59 8 933 935 10.1111/ped.1331428643950 Search in Google Scholar

28 Guidugli L, Johnson AK, Alkorta-Aranburu G, Nelakuditi V, Arndt K, Churpek JE, L at all. A Godley, D Townsley, N S Young, C Fitzpatrick, D Del Gaudio, S Das 1, Z Li 1. Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 2017; 31(5): 1226–1229. GuidugliL JohnsonAK Alkorta-AranburuG NelakuditiV ArndtK ChurpekJE L at all. GodleyA TownsleyD YoungN S FitzpatrickC Del GaudioD DasS LiZ Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes Leukemia 2017 31 5 1226 1229 10.1038/leu.2017.28542079028104920 Search in Google Scholar

29 Tomcikova D, Gerinec A, Busanyova B, Gresikova M, Biskup S, Kortnagel K. Why is it necessary to examine retina when the patient suffers from aplastic anemia? Bratisl Lek Listy. 2018;119(5): 275–277. TomcikovaD GerinecA BusanyovaB GresikovaM BiskupS KortnagelK Why is it necessary to examine retina when the patient suffers from aplastic anemia? Bratisl Lek Listy 2018 119 5 275 277 10.4149/BLL_2018_05129749240 Search in Google Scholar